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I’m going to talk to you tonight about some research which I’ve carried out together with a number 
of colleagues over the last 20 years or so on mental health problems, but in primary care, in general 
practice rather than in specialist psychiatric practice.  You will see, I hope, that this has been a very 
rich area to research and I think our research has had an impact on the care patients receive in 
general practice from GPs and their teams. 
Mental health disorders are very common indeed, affecting as many as one in six people at any one 
time. The 2007 Office for National Statistics (ONS) household survey of adult psychiatric morbidity in 
England found that 16.2% of working-age adults had an anxiety or depressive disorder. Of these 
9.0% had mixed anxiety and depressive disorder, 4.4% were diagnosed with generalised anxiety 
disorder (GAD), 3.0% with post-traumatic stress disorder (PTSD),  2.3% with major depression, 1.4% 
with phobias, 1.1% with obsessive-compulsive disorder (OCD), 1.1% with panic disorder, and 0.4% 
with psychosis including schizophrenia, bipolar or manic-depressive disorder, and other psychoses.  
Together with neurological disorders, mental health problems are the leading cause of disability in 
the UK.  This graph from the United Kingdom Clinical Research Collaboration shows estimated 
disability adjusted life years, which are years of life lost, or spent disabled, due to different 
conditions. As you can see, the biggest bar here in green of disability adjusted life years is for 
neurological and mental health problems.  Now the darker bars represent the percentage of spend 
of UK research money on that area and, as you can see, even though neurological and mental health 
problems are the leading cause of disability, they only get around half the money on research spent 
on them that cancer gets.  Obviously cancer is more commonly fatal, but neurological and mental 
health problems can give you a lifetime of disability and I would suggest we need more research 
funding in mental health.  
The research that I do can be described in a couple of ways which might help you to think where it 
fits in the whole spectrum of research.  When we think of research, a lot of people think about 
genetics, or cellular biology, the study of molecules, cells and tissues, and we do conduct that sort of 
research in our medical school, but we also do quite a lot of research at the level of the person, the 
population and the community. The sorts of methodologies that we would use include health 
psychology, qualitative studies (which involve usually interviews of individuals or focus groups), 
epidemiology (the study of diseases in populations), clinical trials (interventions amongst groups of 
people), and health services research across the different levels of primary, secondary and tertiary 
care in the National Health Service. 
Another way of looking at this is where along the spectrum of translation from basic research into 
health care delivery, my research takes place.   This is quite a well-known diagram from David 
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Cooksey’s review of UK health research five years ago which pointed out that there were two ‘gaps 
in translation’ which needed to be bridged if we were to have more improved health care from 
research.  One is the gap between discovery and design, and getting things into early clinical trials; 
the other gap though is between getting the results of those trials, having demonstrated an 
intervention works, and translating them into actual practice.  This requires assessment of health 
technologies with health economics and health services research, and research into knowledge 
management and delivery of care.  So it’s the sort of research that’s funded by the NHS through the 
National Institute for Health Research Health Technology and Assessment Programme, the NIHR 
Service Delivery and Organisation programme, and the National Institute for Health and Clinical 
Excellence (NICE), rather than the Medical Research Council or Wellcome Trust which might fund 
more basic science research. My mental health research is definitely to be placed in this second gap 
in translation, but it’s nevertheless as important as basic science research – what’s the point of 
laboratory scientists developing new antidepressants for example if they are not taken up and 
prescribed appropriately and cost-effectively? Implementation is crucially informed by health 
services research. 
The first study that I’m going to talk about is a randomised control trial of teaching GPs to carry out 
structured assessments of their long-term mentally ill patients, and this was the main study that I did 
for my Doctorate, my MD at St George’s Medical School, when I was a Mental Health Foundation 
funded research fellow.  We published that 16 years ago in the British Medical Journal and this is an 
example of research which I think had impact on practice, as I will show you.   
This was a man who took part in the research who gave his permission for his photo to be used in 
teaching about the findings. He was 55 and he lived in South London, and was a patient of one of the 
general practices that took part in my study.  He had a lot of continuing mental health problems.  
He’d suffered from schizophrenia since his mid-20’s, so over 30 years he continued to have 
symptoms including hallucinations and delusions.  He could hear voices of people talking to him 
from inside the house. He believed that he was the drummer in Madonna’s band and that he was 
being recorded by the BBC.  He was also on methadone because he’d been a heroin addict back in 
his 20’s and his use of heroin might have contributed to precipitating his schizophrenia.  As well as 
his mental health problems, I think you can see from this photo that he had a number of physical 
health problems.  He had very poor teeth, very poor dentition, never saw the dentist, he had quite 
bad skin problems which you can’t see very clearly here but he had rather poor personal hygiene, he 
tended not to change his clothes from one week to the next and rather neglected his personal 
hygiene and personal care.  In addition he smoked 40 cigarettes a day and that caused him to have 
chronic bronchitis and heart disease, which is ultimately what shortens the life of many people with 
schizophrenia, rather than their mental health problems.  
He lived with his poor old mum who was in her 80s.  The reason they’ve both got their coats on in 
this picture is not because they’re going out but because their heating had broken down.  The 
electricity in fact had failed in their old Victorian house in South London and they were waiting for 
Social Services to get an electrician along to help get things started again, so they were both wearing 
several layers of clothes to keep warm.  I think you can see the care worn expression on his mother’s 
face.  She was actually an auxiliary nurse before she retired, but she’d also been looking after him as 
his personal nurse for 30 years.   
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The reason that I undertook the study for my MD was because we were aware from research that I 
and others had done that GPs’ care of the long term mentally ill was not terribly systematic and was 
often fairly superficial. GPs would tend to treat their patient’s physical problems, give them sickness 
certificates and repeat prescriptions, but they very rarely reviewed their mental state or their 
psychotropic drugs, the drugs for their mental health problems.  Even though people in this group 
tended to be heavy smokers, often obese, not taking any exercise and not turning up for cervical 
screening and other health promotion, GPs didn’t really take much action about that and there 
seemed to be an attitude that the patients’ mental health problems were such that any healthy 
lifestyle advice was rather a waste of time.  Patients in this group sometimes had physical health 
problems which went missed, because the open-ended consultation style that we tend to use in 
general practice, which relies on the patient to come to us, make an appointment, come and tell us 
what’s going wrong with them, doesn’t really work in patients with the apathy and social withdrawal 
which are frequent accompaniments to schizophrenia and other serious mental illnesses.   
So this is what I did for my Doctorate, I carried out a randomised controlled trial.  I set up case 
registers and looked at the records of 440 long-term mentally ill patients in 16 practices.  Those 
practices were then randomly allocated to two groups: eight intervention practices in which I taught 
the GPs to carry out structured assessments of their patients, and eight control practices, which 
carried on with usual GP care. After 2 years I looked at the records of the patients in all 16 practices 
again, to see what care they’d received. In the meantime I looked at 101 of the patients selected at 
random to describe in more detail the problems that they were having and to examine them for 
physical health problems.  The follow-up rate was 373 out of the 440, more than 80%.  
Now this bar chart shows the difference between the patients in the control practices, that’s the 
blue bars, and the intervention practices, the yellow bars, where the GPs were taught the structured 
assessment.  This shows the number of referrals following GP surgery assessments in those patients 
over two years as a percentage of patients in each of the two groups.  As you can see around 15% of 
the control patients were referred to psychiatrists compared to nearly 22% of the intervention 
patients.  More intervention patients were also referred to community psychiatric nurses (CPNs), to 
social agencies, and for physical problems.  This was statistically significant only for the CPN 
referrals, but you can see the general trend is in the direction of more activity in the intervention 
practices. 
And these are psychotropic drug treatment changes. They include changes in neuroleptics (major 
tranquillisers), antidepressants, other mental health drugs, and any change in drug treatments 
including for physical problems.  Again, as you can see the general tendency was for more 
intervention in the practices taught the structured assessment, and overall this was significant at the 
5% level.   
However, the number of structured assessments carried out by GPs was less than perfect.  Only 74% 
of patients even had a first assessment carried out, so a quarter of patients didn’t get that done.  
That dropped to about half of the patients having two assessments, 30% having three, and only 1 in 
6 patients having all four planned assessments over the six months.  This was because, when talking 
to the GPs they found it quite difficult to fit this into their practice, and without extra resource to 
fund special sessions where they and the practice nurse could get together with these patients, this 
wasn’t going to happen just voluntarily.   
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I was pleased therefore that, in the 2003 GPs’ NHS contract, and the revised GP contract of 2006, 
performance indicators were put in for setting up registers of patients with severe mental health 
problems and reviewing them annually. Here you can see that GPs were awarded up to 23 points 
(out of a total of 1000 for clinical care) for the percentage of patients reviewed within the last 15 
months.  The extra three months is so that GPs could chase people up that hadn’t been along in a 
year.   
The annual review of patients with severe long-term mental health problems incentivised in the GP 
contract included these elements: health prevention and promotion, a check on alcohol, drugs, and 
smoking, a check for heart disease and diabetes, and checks on psychiatric medication, community 
mental health nurse involvement, and what services were actually being received by the patients 
and their carers. These reviews usually involve the practice nurse as well as the GP. It’s important 
that these reviews are done well, and I was interested to learn recently that Jacquie White and 
colleagues in the Faculty of Health Sciences here in Hull run a training programme for practice teams 
in this area. 
In the first couple of years after these indicators were introduced, most practices, virtually 100% 
across the country, set up registers of their patients with severe and enduring mental illness, and at 
least three-quarters and getting on for 90% in Southern England, where there’s probably less 
deprivation and it might be easier to make these changes and practices are perhaps a little less busy, 
practices had managed to review more than 90% of their patients in order to earn the full 23 points 
that they could get.  The average completion of reviews earned 21 out of 23 points so at least at the 
process level, the work that I did, along with research by others in the same area, had an impact. 
Whether these reviews improve the outcomes for patients is another question, and I am currently a 
minor member of a team led by Rowena Jacobs, of the Health Sciences Department at York, looking 
at whether the completeness and quality of regular reviews of these patients is associated with 
lower rates of admission to hospital.  
I’m largely outlining a medical approach to mental health this evening, and the medical model is 
often criticised as inadequate in this field. I agree, we should think of mental health in terms of a 
whole range of psychological and social factors too, factors which can affect us positively as well as 
negatively. The good looking man in the middle of this picture is a long-time colleague and friend of 
mine, Chris Dowrick, professor of primary medical care at Liverpool medical school. This picture 
shows us walking together with another colleague Peter Salmon, a health psychologist in Liverpool. 
Chris invited me to walk with him in the Sierra Nevada in Spain when I was a bit down myself, going 
through a divorce at the time. Good friends are one of the things that can promote our mental 
health. 
The second study I’m going to talk about is a study that I carried out with two medical students, 
Fiona King and Louise Albertella, who were doing their  year medical student research projects in 
Southampton, and with Peter Smith, Professor of Statistics.  I’d moved to Southampton in 1998 to 
take up the Chair there and I became interested now in depression.  Professor Chris Thompson and 
others there had carried out the Hampshire Depression Project a large well conducted study that 
found that teaching GPs how to treat depression better according to guidelines was unsuccessful. 
Analysis of the study suggested GPs were treating some patients who didn’t need treatment, while 
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not treating others who did need it.  So I was interested in looking more closely at how GPs decided 
which patients needed treatment.  
This was a study where the medical students sat in the waiting room of participating general 
practices and screened patients with a questionnaire, the Hospital Anxiety and Depression Scale 
depression sub-scale, or HAD-D, before the patients went in to see the doctor.  They were looking 
for new cases of depression that were unknown to the Practice.  The doctors then independently 
rated the presence and severity of depression amongst the patients as they consulted, blind to the 
scores that the patients had received in the waiting room, and recorded whether they had 
acknowledged depression with the patients, whether they’d offered them antidepressants, or 
referred them for psychological or psychiatric treatment.   
This table shows that the GPs rated a total of 101 patients out of the 669 as depressed. A positive 
relationship is seen between the GPs’ perceptions of the severity of the patient’s depression along 
the top and offers of antidepressants down the side.  As you can see, 71 were thought to have mild 
depression and 30 moderate depression. The numbers who were offered antidepressants was 4% of 
the 71 with mild depression, and 37% of those with moderate depression.  So there was clearly a 
relationship between GP perception of severity of depression and whether or not they were offered 
antidepressants, which is what you would expect.  
However, this table shows you the relationship between GP diagnoses of depression and the 
patients’ scores on the HAD-D questionnaire. Where patients score 8 or more on the HAD-D they’re 
rated as a possible case of depression.  Across the top here again you can see the GP diagnosis of 
depression.  They thought that 101 were depressed out of 669 and 568 were not.  Down the middle 
there you can see that according to the HAD-D, 97 were rated as depressed and 572 were not.  So 
similar numbers of patients overall were classed as depressed, about 100 out of the 669, but of the 
97 who were a case of depression according to the HAD-D, only 31 were diagnosed as depressed by 
the GP and 66 were missed, which means that the sensitivity of the GPs for diagnosing depression 
against the HAD-D was only 32%.  So GPs are not terribly good at picking up depression in a global 
way when compared to a questionnaire like the HAD-D, which has been shown in other studies to be 
a valid indicator of depression diagnosed by a longer psychiatric interview.  
This fed through into the offers of antidepressants so as you can see from this table, out of the 14 
patients offered antidepressants, only two of them (14%) had scores of 11 or greater on the HAD-D, 
which equates to probable major depression, six (43%) had scores in the borderline area, possible 
major depression, and another six, 43%, had scores of less than 8, which means that major 
depression is unlikely.  So 43% of these offers were being made to patients with scores suggesting 
depression was unlikely.   
We recommended better ways to assess depression severity should be used than GP judgement 
alone, to target treatment more appropriately to patients with more severe depression. This study 
was considered by the expert group reviewing the GP contract Quality and Outcomes Framework in 
2005. Subsequently, in the revised QOF from 2006 onwards, up to 25 points were awarded for a new 
indicator which rewarded the use of an assessment tool, validated for use in primary care, at the 
outset of treatment. So that study I think had impact, at least in terms of changing what GPs were 
asked to do in the Quality and Outcomes Framework in 2006, when depression was included in the 
framework for the first time. 
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Music I think can also promote mental health. Certainly I have had huge pleasure from the Rolling 
Stones over many years. Listen to the words of Mick Jagger and music of Keith Richards from 
Mother’s Little Helper, 1965: 
“Kids are different today, I hear every mother say 
Mother needs something today to calm her down 
And though she's not really ill, there's a little yellow pill, 
She goes running for the shelter of a mother's little helper, 
And it helps her on her way, gets her through her busy day” 
The Stones were talking about Valium, which was prescribed widely and fairly indiscriminately in the 
1960s and 1970s before a ruling from the Committee on the Safety of Medicines in 1980 warned of 
its propensity to cause dependence.  This brings me onto this increasingly widely prescribed drug, 
Prozac. Prozac was the first of a new class of antidepressant, the selective serotonin reuptake 
inhibitors or SSRIs, and was first licensed for use in 1990.  Since then the numbers of SSRIs 
prescribed has increased steadily, year on year.  
This is a bar chart of trends in the prescribing of mental health drugs in general practice in England, 
from the Prescription Pricing Authority which collects together all our GP prescriptions.  Now as you 
can see, the total number of prescriptions rose between 2000 and 2005, from around 10m to around 
12m items per quarter.  Now the drugs that we’re interested in, the SSRIs, the Prozac type drugs, are 
represented by the dark blue bars, the second lot of bars up, and as you can see they increased from 
about 5m to over 6m prescriptions per quarter during that period,.  Other newer antidepressants, 
represented by the yellow bars, were also increasing.  The red bars at the bottom are the older 
tricyclic antidepressants, amitriptyline, imipramine, and others.  As you can see, the SSRIs and newer 
antidepressants are being prescribed in addition to a baseline of more than 2m items per quarter of 
the older antidepressants, which have not reduced, so the newer ones are not replacing the older 
ones.  They are in addition and they’re the main reason why the total number of prescriptions is 
going up and up, year on year. This is a process which is still continuing so we were interested to 
unpick why the prescribing of antidepressants was increasing.  
To look into this increasing prescribing of antidepressants, we carried out a descriptive study using 
the General Practice Research Database, the GPRD, which is a large database of routinely collected 
computer data from general practices all up and down the country. This study was carried out with 
Mike Moore and Nick Dunn, colleagues in Primary Medical Care in Southampton, and Brian Yuen and 
Mark Mullee in Medical Statistics there.  It was funded by the National Institute for Health Research; 
you remember this sort of research which is over towards the right-hand end of the translational 
spectrum tends to be funded more by the NHS than the MRC.  
The possible causes of year on year rises in antidepressant prescribing in general practice could be 
an increase in the true incidence of depression; an increase in the diagnosis of depression perhaps 
due to improved recognition or changing thresholds for diagnosis; an increase in the proportion of 
cases of depression who are treated with antidepressants; or an increase in the duration of 
prescribing, so that the average number of prescriptions for a similar number of patients increases 
overall. 
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The GPRD is a huge database.  At its height in 2001 it had more than 3m patients in it as you can see 
here and it’s currently around 2m patients.  The practices that contribute to this resource upload 
data from their practice computers anonymously to a central database.  One of the challenges in 
using the GP Research Database is that the numbers of practices and the numbers of patients have 
varied over time as you can see.  To get round this problem we selected only practices which were in 
the GPRD right throughout the period for which we had data, from 1993 to 2005.  
So the first question I raised was whether the incidence or diagnosis of depression was increasing.  
Well this is the incidence of diagnosed depression in the GPRD and as you can see it remains 
relatively flat between 1993 and 2005, and in fact there might have been an increase during the 
nineties which then tailed off a bit during the noughties. Overall it’s fairly steady at a rate of around 
10 per thousand, or 1% per year. Remember these are new cases only, not all cases, which would be 
around 5 to 10% per year. The lines show the usual situation found in studies of the incidence of 
depression, which is that women are diagnosed twice as often as men, which I don’t think is 
surprising.  After all women do all the caring, they bring up the children, they look after the old 
people, they have all the hormonal issues to deal with, premenstrual tension, childbirth and the 
menopause, and women generally get the rawer deal in life so it’s not surprising to me that 
depression is twice as common in women.  
This chart shows that diagnosis was most common in young women, particularly in women of aged 
18-30, here shown by the orange line, where you can see the rate of diagnosis of depression is 
around 30 cases per 1000 so that’s about one in 30 young women being diagnosed as depressed 
each year.  This is a lot more compared to women in older age groups where there was a slight rise 
amongst the under-18s, but for the 31-64 year olds and the over 65s, generally the trend was to 
diagnose less depression between 1993 and 2005, and actually I’m not that surprised about this 
because generally speaking it was a period of relative affluence and probably reduced deprivation 
over time.   
The second question was whether we were treating more of these new cases with antidepressants 
and again the answer is no, not really.  In fact, if anything, during the 2000’s the proportion treated 
dropped off a bit from around 80% to around 75%.  This is rather circular because GPs often only 
attach a diagnosis of depression to people if they’re going to treat them with antidepressants, so it 
may be that there are other patients that they think are depressed but don’t attach a label to 
because they’re not going to treat them.  Having a label of depression in your GP records is not 
always the best thing for a patient because employers, insurance companies, and others can come 
along afterwards and ask for reports from a GPs’ records and, unfortunately these days, although 
we’d rather it wasn’t, depression is still a stigmatised disorder.  At any rate, around 80% of those 
labelled with depression were treated with antidepressants and that stayed much the same during 
the period 1993 to 2005.   
So were people being treated for longer over time?  Well our initial analysis suggested not.  These 
bars represent the proportions of patients who had different durations of treatment in the first two 
years after diagnosis and as you can see in 1993 to 1994 around half (55%) of the patients diagnosed 
actually had only 30 days or less of treatment prescribed. Around 20% had one to two months of 
treatment; around 10% had two to three months; around 10% had three to six months, and only 
around 5% of patients had more than six months worth of prescriptions.  This is interesting because 
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the recommended duration of treatment for a first episode of depression would be more than six 
months according to NICE guidelines, but only 5% of patients were getting that duration of 
treatment prescribed.  The situation hadn’t really changed in 2004 to 2005.  You can see here that 
the sizes of the bars look much the same, and again only about 5% of patients were treated for more 
than six months.  
However, we found that the mean number of prescriptions of antidepressants per patient per year 
was going up steadily in our sample, so although more people were not being treated, and it looked 
on the surface that the duration of treatment was staying much the same, the number of 
prescriptions per patient per year was going up from around three to almost six, nearly doubling 
during this time period. This rise of course mirrored what was happening at the national level, where 
prescriptions for antidepressants were going up year-on-year.  So how could we explain this?  It was 
a bit of a mystery but we thought to understand better what was going on we had to look at 
individual patients and what happened to their treatment over some years after diagnosis.  
So we split the patients into five groups.  Those who received what we call chronic treatment were 
those who received at least one prescription in the year of diagnosis and in every year after that for 
five years; those who received intermittent treatment received at least one prescription in the year 
of diagnosis and in at least one of the five subsequent years; those who received short term 
treatment received a prescription in the year of diagnosis but not in any of the five subsequent 
years; delayed treatment meant no prescription was received in the first year of diagnosis but a 
prescription was given sometime between years two and five; and finally we had a no treatment 
group where patients were given a label of depression but never received a prescription for an 
antidepressant. 
Now this chart takes a little bit of getting your head round.  Over on the right you can see the colour 
key for patients who received the various patterns of treatment: the chronic treatment group is 
represented by the blue bars; intermittent treatment by the dark red bars; short term treatment by 
the pale yellow bars; and delayed treatment by the pale blue bars.  You can’t see the no treatment 
group on this chart because this is a chart of prescription days, so everyone on here received some 
treatment.  As you can see in the two long term use groups, the chronic treatment and the 
intermittent treatment groups, the number of prescription days does increase over time.  Amongst 
the patients receiving short term or delayed treatment it remains much the same. The two  longer 
treatment groups were relatively small, but they were the ones receiving more and more 
prescriptions year-on-year and their treatment patterns explained the cause of the rise in the 
average number of prescriptions per patient.  
The implications of the findings of this study were that, instead of looking at the initial prescribing 
decision and trying to improve the targeting of drug treatment to more severe depression, which is 
what we’d done up until that point, increased attention should focus in the future on appropriate 
longer-term prescribing in the small number of patients who end up on long term antidepressants.  
Other research we did led by Gerry Leydon showed that some of those patients were often not 
being monitored and having their need for medication reviewed regularly. Some wanted to come off 
their medication but found it hard and needed help to do that. We concluded there is a small but 
growing number of patients, particularly of young women, who are taking Prozac and other drugs 
like that for depression year-on-year and really ought to be reviewed so the question can be raised 
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with them about whether they should come off the drugs. Strictly speaking, the SSRIs are not 
addictive because, unlike Valium, people taking them don’t develop tolerance to their effects and 
need more and more of them, but they do have withdrawal symptoms associated with them 
including anxiety symptoms, and need to be tapered off slowly with advice and supervision from the 
doctor.  
Families can obviously be the cause of depression as well as prevent depression through mutual love 
and support. I am extraordinarily lucky to have two parents still alive and well and enjoying regular 
cruises, and two lovely kind and successful children, Celia and Patrick, now in their mid-20s. Here’s a 
picture of them altogether on the cliffs between Deal and Dover where I grew up.  
The fourth study I’d like to talk about is a study of the management of depression in general practice 
in relation to scores on the depression severity questionnaires which you will recall we 
recommended should be introduced and rewarded through the GP contract Quality and Outcomes 
Framework.  We were interested to look at the use of these questionnaires and whether prescribing 
was influenced by the results obtained using them with patients.   I worked with Chris and 
colleagues from Southampton as well as Amanda Howe’s primary care group at East Anglia medical 
school. This study was funded through unrestricted educational grants from four manufacturers of 
antidepressants, who were interested in learning more about influences on GPs’ prescribing, but 
they had no say in the questions we asked, the methods we used, or the results we presented. 
We were interested in looking at whether rates of antidepressant prescribing and referrals to 
specialist services varied in line with patients’ scores on the QOF severity questionnaires. The two 
questionnaires that we looked at were the two most commonly used measures, the Patient Health 
Questionnaire nine item version, or PHQ-9, and the Hospital Anxiety and Depression Scale, 
depression sub-scale or HAD-D, which I’ve mentioned we used in the previous study of detection 
and rating of severity of depression.  We realised that it was unlikely to be the scores on these 
measures alone that would determine rates of antidepressant drug prescribing by GPs, and we 
looked at other potentially important predictors that the GPs would take into account, including the 
age of the person, any past history of depression, and any concurrent physical illness, in particular 
diabetes and coronary heart disease, where GPs might think twice about prescribing antidepressants 
because of the potential negative side effects of treatment on those conditions.  
In 38 general practices between Southampton, Liverpool and Norfolk, we looked at over 2,000 
patients who were assessed with the severity questionnaires in the first year of their introduction, 
2006-2007, specifically at rates of prescribing of antidepressants and referrals to specialist mental 
health or social services (you can see the types of mental health worker that were included in those 
referrals there). 
This table shows down the side whether or not patients were prescribed an antidepressant and 
whether or not they were referred to mental health or social services. Across the top is shown the 
severity of patients’ depression according to their scores on the PHQ-9 questionnaire.  As you can 
see, a total of 1,658 patients were assessed with the PHQ-9, and of those 1,384 were rated as 
moderate to severely depressed, 189  as mildly depressed and 85 as minimally depressed. The rates 
of prescribing for these groups of patients do vary in line with the severity according to the 
questionnaire. You can see in the moderate to severe depression category nearly 87% of patients 
received a prescription, whereas in the minimal depression category only 27% did.  Overall 79% 
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received a prescription for an antidepressant which was in line with what we found in the GPRD 
study I mentioned earlier.  In terms of referral, again there was a relationship with severity rated by 
the PHQ-9.  Only about one quarter of patients were referred overall, but that varied from 13% of 
those with minimal depression, through 16% of those with mild depression, to 25% of those with 
moderate to severe depression. 
Now if we look at the HAD-D questionnaire ratings a similar picture emerges.  The chances of 
treatment with an antidepressant and referral are both related to severity of depression according 
to the HAD-D questionnaire, in a similar fashion to the PHQ-9 results. 
However, things are never that simple, and we really had to raise a question mark over whether the 
scores on the two questionnaires were in reality informing the decision to refer and treat because 
the classification of patients according to these two different measures revealed quite different 
profiles.  The PHQ-9 was more likely to put people into the moderate to severe depression category 
than the HAD-D. Here you can see among both men and women, about 80% of those rated with the 
PHQ-9 were put into the moderate to severe category, whereas amongst the HAD-D it was only 
about 60%, and yet the proportions of patients rated with either measure who were treated with 
antidepressants and/or referred were the same.  So we thought we had to be sceptical really about 
whether the scores were informing the GPs’ decisions to prescribe or refer.  
We put together a logistic regression model, which is a statistical model which includes several 
factors together which between them might help to explain GPs’ prescribing or referral decisions. 
These factors were the severity of depression, older age, a past history of depression, having 
diabetes or coronary heart disease, and the location where the practices were based, because there 
is evidence that practices in some towns are more likely to prescribe than practices in others, 
because the local prescribing culture varies.  We found that Southampton practices had quite a high 
level of prescribing compared to practices in the other two cities we studied.  Here you can see the 
logistic regression models for the two measures and, even when putting all these factors in together, 
for both the PHQ-9 and the HAD-D assessed patients, prescribing was very much related to severity 
(the three pluses there show that receiving a prescription was related to severity). In addition, 
amongst the HAD-D rated patients, when taking these other factors into account, referral was still 
also related to severity.  Referral was negatively related to being aged over 65 for both groups of 
patients, so elderly patients were much less likely to be referred, independently of whether they had 
a past history or diabetes or heart disease.  A past history was a predictor of prescribing in PHQ-9 
rated patients but not HAD-D rated patients, and having diabetes or heart disease was a negative 
predictor of both prescribing and referral in the PHQ-9 group, so if you had diabetes or coronary 
heart disease you were much less likely to be either treated or referred at least among the PHQ-9 
rated patients.  
To summarise the findings of this study, overall about 80% of patients assessed with either 
questionnaire received a prescription and about 20% were referred to specialists. Prescriptions and 
referrals were associated with higher severity measure scores, but the overall rates of treatment or 
referral were very similar for patients assessed with the two different measures, despite the fact 
that the PHQ-9 classified more than 80% of patients as moderately or severely depressed and in 
need of treatment, compared to only about 55% for the HAD-D.  Finally, rates of intervention were 
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lower for older patients and for patients with co-morbid (accompanying) coronary heart disease and 
diabetes.   
To summarise this work that I’ve shown you on the GP use of antidepressants, the diagnosis of 
depression and prescribing of antidepressants by GPs has remained remarkably consistent through 
the nineties and the noughties: about 80% of patients diagnosed are treated with antidepressants, 
but most patients take them for too short a time compared to guideline recommendations of six 
months.  On the other hand, a small proportion of patients are kept on them long-term which 
explains the rise in prescribing, but may be too long in some cases.  Analysis of patients’ records 
suggests GPs largely decide on drug treatment on the basis of severity but they also take age and 
physical illness into account. The two most widely-used severity questionnaires perform 
inconsistently in practice, which has brought them into disrepute and their inclusion in the QOF may 
actually be discontinued from April 2012, which will be welcomed by many GPs as many don’t like 
using them. Simon Gilbody and I are involved in a multicentre research project to look again at the 
best predictors of the need for antidepressants, including severity scores on questionnaires, funded 
by an NIHR programme grant led by Glyn Lewis in Bristol and involving Chris Dowrick in Liverpool. 
However, future research and policy also needs to focus on the duration of prescribing and follow-
up monitoring of people put on these drugs long-term, as well as the initial decision to prescribe.  
A sense of community is important to our mental health, a sense of belonging to a wider group, of 
sharing a common interest and purpose. This is a picture of members of my old running club in 
Romsey at the end of the annual five mile beer race. All finishers are rewarded with a pint of London 
Pride which is just what you need after five miles up and down the hills of Hampshire. Alcohol in 
small amounts can help our mood, but of course too much alcohol too often causes rather than 
relieves depression. 
I want to turn away from drug treatment now. The next study I want to talk about is a qualitative 
study, an interview based study that we carried out with patients, their carers, and GPs about 
depression management in primary care.  We wanted to identify what were the GPs’ goals and the 
patients’ goals when managing depression and what came out strongly in this study was the value to 
patients of being heard, of being listened to.  This was led by Olwyn Johnston, a Health Psychologist; 
and the team included Satinder Kumar a GP and Anthropologist; Kathy Kendall, a Medical 
Sociologist; John Gabbay, a Public Health Doctor; and Robert Peveler, a Psychiatrist; so we were very 
much a multidisciplinary group. It was funded by the Medical Research Council and published in the 
British Journal of General Practice in 2007. 
We interviewed 28 depressed patients and 32 GPs, and we found that patients valued being listened 
to very much. These were the sorts of benefits which may or may not be immediately obvious. First 
of all, a sense of connection, helping the patients to feel understood by the doctor.   They valued the 
process of reflection, helping people to clarify or reframe either what was wrong with them, using 
the medical model, or what was wrong with their situation, adopting more of a social model, to help 
explain their depression.  They valued being listened to for the sense of acceptance, that the doctor 
would accept them for who they were even when others were condemning them for their 
behaviour. Sometimes just bearing witness to the suffering that people are going through can be 
helpful even if you’re not actually doing anything to change their situation.  Reassurance is 
important, in particular that people who are depressed are not going mad. Ventilation, catharsis is 
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helpful obviously, to help people get things off their mind, and the doctor’s can be a safe place 
where they can sound off and talk about things.  But encouragement is also very important, because 
most people, the large majority of people with depression, do get better and people need 
reassurance about this, because often people feel they are never going to get better and they’re 
going to end up disabled, and on long term treatment. The great majority won’t. 
Unfortunately, in general practice patients often don’t feel very listened to.  There’s often a 
perceived lack of time, the doctor seems rushed, and even 10 minute appointments (which have 
lengthened during my working lifetime from five minutes) aren’t long enough for people to describe 
their feelings and feel they’ve been heard.  Doctors often seem to be preoccupied with the 
computer or making notes, and not giving the person enough attention.  There’s sometimes a 
perceived lack of receptiveness or acknowledgement of their problems as worthy of discussion.  The 
patient feels less worthy than those with physical illness and the doctor may even dismiss the 
problems as not worthy of medical attention.  Or if the doctor does respond, the doctor decides too 
quickly to reach for the prescription pad and offer antidepressants. However, patients don’t mind so 
much if the GP doesn’t do much talking and listening with them if they are being referred on to 
someone else who will listen, perhaps a counsellor or another professional to give them some sort 
of talking treatment. 
Loving and being loved is also related to our mental health, one way or the other. I’d like to thank 
my partner Dr Helen Mander, who works in Hull as a clinical psychologist, for all the love and 
support she gives me. So I have my own personal therapist, how great is that? I think counting your 
blessings, especially your friends, family and loved ones, is a really important thing to try and do 
every day. Helen says psychologists call that having a positive data log, and it’s part of a cognitive 
behavioural approach to treating depression. That brings me on to psychological treatments, which 
is what most patients prefer, although for many years they have been relatively unavailable in most 
parts of the country, which helps explain why GPs prescribe antidepressants, the lack of an 
alternative to what many of us realise are very imperfect drugs. 
I was delighted to be asked to join a team from the Universities of Sheffield, Manchester and London 
while I was at Southampton, to look at a new service model of providing talking treatments, the 
Improving Access to Psychological Therapies (IAPT programme).  The IAPT programme was set up in 
two demonstrations sites and our project helped evaluate them between 2006 and 2009. IAPT is a 
new service introduced to give much greater access to talking treatments for people with anxiety 
and depression, who can be referred from general practice or hospitals, from social services, or self-
referred.  This study was funded by the National Institute for Health Research Service Delivery and 
Organisation programme, and is very much at the right hand end of that translational spectrum that 
I showed you at the beginning of the lecture. 
The Improving Access to Psychological Therapies programme includes two steps of care, low 
intensity which includes guided self-help, helping people to help themselves which might be through 
using books or computer programmes, to help them identify and challenge negative automatic 
thoughts, and through behavioural activation, helping them to get out more, to increase their daily 
activities, and face the things that make them anxious, because we know that this graded exposure 
can be helpful in itself.  Often low intensity treatment is delivered over the telephone in four to five 
sessions of around 45 minutes, which is relatively short.  The second step is high intensity treatment, 
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for those who don’t respond to low intensity treatment, which may be 15 to 20 one-hour sessions of 
cognitive behaviour therapy which is a much more detailed therapy which tackles the person’s 
negative thoughts and behaviours, or interpersonal therapy which looks more at how people deal 
with their important others.  In this study we looked at the effects of the IAPT programme in the two 
demonstration sites: in Doncaster in the north, and Newham in South East London in the south.   
To summarise the main findings of the study, these demonstration sites were very successful.  They 
were able to treat hundreds of patients every month, most patients receiving low intensity therapy 
delivered over the telephone, lasting 4-5 sessions each.  This was so successful that six times as 
many patients received treatment than previously, which is fantastic, except when you realise that 
the absolute increase was only from 1%, that’s one in a hundred patients, to 6%, six in a hundred of 
those with some sort of mental health problem actually receiving a talking treatment.  Nevertheless, 
amongst the 6%, their use of accident and emergency was reduced so people were turning up at 
hospital much less often with problems of anxiety and depression needing help urgently, and 5% 
more patients in the IAPT group got back to work, than in the usual GP care group.  So it was 
successful to that extent. 
There were also a number of problems identified with the IAPT programme.  Patients found it quite 
a problem if they didn’t see the same person each time and because of staff turnover there was 
often a lack of continuity or follow-up for patients.  For some people practitioners who contacted 
them over the phone could be experienced as impersonal when compared to professionals from 
their own practices.  Some patients felt that they didn’t really have much choice, they would have 
preferred more of a counselling approach or some other approach that they were used to from the 
past, and they felt shoe-horned into this possibly rather restrictive model, the two-step model of the 
IAPT programme.  And although hundreds more patients received treatment, as I’ve said they were 
still only a small minority of the total number of patients with anxiety and depression.   
This slide summarises some of the work that we’ve done on talking treatments.  People need to feel 
listened to. There are all sorts of reasons why it’s important for them.  It may go without saying that 
that is obvious but it often doesn’t happen in practice.  GPs often can’t or don’t listen enough and 
the same may go for practice nurses who are often busy with practical tasks.  Referral for some sort 
of talking therapy can be very helpful but even with the increased access provided by the IAPT 
programme, only a minority of patients who might need referral can get it due to the limited funding 
available, and that’s likely to get worse as the NHS makes its 20% efficiency savings over the next 
few years.  Some people anyway find outside therapists rather impersonal and so one of my 
conclusions is that primary care teams may have to do more themselves. If they do that then the 
training of people who are offering talking therapies in primary care, together with supervision, 
some regular feedback on how they’re doing, will be essential to maintain the quality of treatment 
provided.   
I have mentioned some other potential treatments for depression in passing, and one of them which 
is currently under-rated is regular exercise.  Exercise has done me a power of good. Over the last few 
years I have been running marathons, at least two marathons a year and this is a picture of me 
recently taking part in the Chicago marathon in the States.  I think that regular exercise is keeping 
me sane, I think it really helps me if I find the time to put in long distance runs, I find I think more 
clearly, and I can take on the daily demands of being the head of a medical school. I’m not sure why 
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exercise helps you. It has been shown to increase the level of endorphins, those natural morphine-
like hormones which can flood into the blood on long runs, when you’re really away in the zone, in a 
meditative like state, and everything around you melts into the background, like in this picture. 
On the other hand, maybe you go through so much pain while you’re running that the rest of life 
seems wonderful by comparison, but it doesn’t necessarily do wonders for your looks. This is a 
picture of me running The Grim which is a cross-country run in freezing December through flooded 
tank traps and deep yellow mud on an army assault course near Aldershot. Does this remind you of 
anything?  
It reminded me of one of those Gremlins from the movie. I think we feel better if we’re able to laugh 
at ourselves, and not take life too seriously sometimes. Humour then is another possible therapy for 
mental health problems. 
I’d like to finish by thanking some of the many people with whom I have had the privilege of working 
on the projects that I’ve talked about, and other projects too numerous to include in this talk. From 
my great late mentor, Paul Freeling, who inspired me to go into general practice, first as a student 
and then later as a research fellow; through to colleagues at HYMS with whom I’m doing research 
today, like Simon Gilbody. Some colleagues are here in the audience.  I’m really pleased that Chris 
Dowrick from Liverpool has been able to make it.  He’s an old mate and we’ve been involved in 
several studies together. Research is a business that really engages you with other people and I hope 
that I’ve shown that work on mental health problems is all about people.  It’s work at the level of the 
person, and the community, so it’s not molecular biology but I think you’ll agree that it’s still very 
important research.  Thank you for listening. 
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Down at the Doctor’s 
 
How should GPs and their teams help 
people with mental health problems? 
Tony Kendrick 
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Mental health problems: very common 
Prevalence among16-64 year olds: 
 9.0% mixed Anxiety and Depression 
 4.4% Generalised Anxiety Disorder 
 3.0% Post-Traumatic Stress Disorder 
 2.3% Major Depressive Disorder 
 1.4% Phobias 
 1.1% Obsessive Compulsive Disorder 
 1.1% Panic Disorder 
 0.4% Psychosis (Schizophrenia, Bipolar Disorder,  and 
other psychoses)   
McManus et al, Psychiatric Morbidity Survey 
Office for National Statistics, 2007. 
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Level in system Example of research 
Atoms Imaging 
Molecules Genomics, proteomics 
Organelles Mytochondrial biology 
Cells Cellular biology 
Tissues Matrix biology 
Organs Hepatology 
Body system Cardiovascular  
Person Health psychology, qualitative studies 
Population Epidemiology, clinical trials 
Community Health services research 
Ecosystem Ecology 
Biosphere Environmental research 
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The need for clinical and health 
services research 
Cooksey D.  A review of UK health research 
funding.  London: Stationery Office, 2006 
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Randomised controlled trial of teaching 
general practitioners to carry out structured 
assessments of their long-term mentally ill 
patients  
 Tony Kendrick, Tom Burns & Paul Freeling 
St George’s Hospital Medical School 
 
Funded by the Mental Health Foundation 
 
British Medical Journal 1995, 311, 93-98 
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What were GPs doing for their long-
term mentally ill patients? 
 Treating physical problems and issuing 
certificates and  repeat prescriptions 
(Parkes et al 1962, Kendrick et al 1994) 
 Reviews of mental state and psychotropic 
medication were relatively uncommon  
(Nazareth et al 1993, Kendrick et al 1994) 
 Health promotion was almost non-
existent (Kendrick, 1996) 
 Open-ended consultation style tended to 
miss problems in patients with apathy and 
withdrawal 
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Case registers set up 
Records examined 
8 control practices 
- usual GP care 
8 intervention practices 
 - GPs taught structured  
    assessment  
Records examined two  
years after intervention 
Sample interviewed 
 and examined 
Design  16 practices 440 patients 
101  
patients 
373 patients 
6-monthly 
assessments 
11 
Referrals following GP surgery assessments 
(% of patients over two years) 
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Psychotropic drug treatment changes  
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Structured assessments carried out by 
GPs over 2 years 
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New General Medical Services Contract  
Quality and Outcomes Framework 2003 
Indicator Points Payment stages 
MH1  Register of patients with severe 
long-term MH problems 
7 
MH2  % of patients reviewed within 
the last 15 months 
23 25 – 90% 
NHS Confederation/BMA, 2003 and revised 2006.  
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Annual review of patients with severe 
long-term mental health problems 
Physical care  
 Routine health promotion and prevention 
 Alcohol or drug use  
 Smoking and heart disease 
 Risk of diabetes 
Medication  
 Accurate, up to date 
Coordination of services  
 Community mental health nurse involvement  
 What services are actually being received by the patients and their 
carers  
General Medical Services Contract  Quality and Outcomes Framework 
NHS Confederation/BMA, 2003 and revised 2006.  
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Quality and Outcomes Framework  
MH 1 and 2 indicators 2004-5 
 
Region 
% of practices with a 
register of patients with 
severe mental illness 
% of practices which 
reviewed >90% of 
patients with SMI 
NW England 99.4 76.0 
NE England 99.2 77.4 
London 99.3 77.0 
Eastern England 99.3 85.2 
Southern England 100 87.8 
Average points for completion of patient reviews = 21 / 23  
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GP treatment decisions for patients with 
depression: an observational study 
 
 
Tony Kendrick, Fiona King, Louise Albertella & Peter Smith  
 
University of Southampton 
 
British Journal of General Practice 2005;55:280-286. 
19 
Methods 
 669 patients screened in waiting room with Hospital 
Anxiety and Depression Scale depression sub-scale 
questionnaire (HAD-D) before seeing the doctor         
(excluding people with known depression) 
 The doctors rated the presence and severity of 
depression and reported whether they: 
 Acknowledged depression 
 Offered antidepressants 
 Referred for psychological treatment 
 Referred for psychiatric opinion 
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Perceived severity and offers  
of antidepressants 
   
GP  perception of severity of 
depression 
 
 
 
 
   
mild 
 
 
moderate 
Total 
Whether or 
not patient 
was offered 
anti-
depressants 
 
No 
 
 
68 
 
19 
 
87 
 
Yes 
 
 
3 (4%) 
 
11 (37%) 
 
14 
 
 
 
Total 
 
 
71 
 
30 
 
101 
 
    Fisher’s exact test  p < 0.05 
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GP diagnoses of depression compared 
to the HAD-D 
 
 
                                Sensitivity = 32%   
 
  Whether or not a case on 
the HAD-D (score 8+) 
 
 
 
   
Yes 
 
 
No 
 
Total 
 
GP 
diagnosis 
of 
depression 
 
Yes 
 
 
31 
 
70 
 
101 
 
No 
 
 
66 
 
502 
 
568 
 
 
 
Total 
 
 
97 
 
572 
 
669 
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HAD-D scores of 14 patients offered 
antidepressants 
0-7  
(major depression unlikely) 
6 (43%) 
 
8-10  
(possible major depression) 
6 (43%) 
11+  
(probable major depression) 
2 (14%) 
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Implications for practice 
 Better ways to assess depression severity are 
needed in order to target treatment more 
appropriately 
 Fed into expert group reviewing the QOF 
 In the revised QOF from April 2006, up to 25 
points were awarded for a new indicator: 
 In those patients with a diagnosis of depression, the 
percentage of patients who have an assessment of 
severity, using an assessment tool validated for use in 
primary care, at the outset of treatment 
24 
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Music 
“Kids are different today, I hear every mother say 
Mother needs something today to calm her down 
And though she's not really ill, there's a little yellow pill, 
She goes running for the shelter of a mother's little helper, 
And it helps her on her way, gets her through her busy day” 
 
Jagger M, Richards K. Mother’s little helper. 1965. 
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The new Valium? 
27 
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Explaining the rise in antidepressant 
prescribing: a descriptive study using the 
General Practice Research Database 
Mike Moore, Ho Ming (Brian) Yuen, Nick Dunn, Mark Mullee 
&Tony Kendrick 
  
Primary Medical Care and Medical Statistics, 
University of Southampton 
 
Funded by the National Institute for Health Research 
 
British Medical Journal 2009;Oct 15;339:b3999 
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Possible causes of increased prescribing 
 An increase in the incidence of depression 
 An increase in the diagnosis of depression 
 Reflecting improved recognition or changing 
thresholds for diagnosis 
 An increase in the proportion of cases treated 
 An increase in the duration of prescribing 
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Number of patients in the GP Research Database 
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Incidence of first recorded episode of 
depression (per 1000 patient-years)  
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Incidence of first episode depression in 
women by four age bands 
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Percentage of new cases treated with 
antidepressants 
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Duration of initial treatment 
35 
Mean number of prescriptions of 
antidepressants per patient per year 
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Five treatment patterns over five years 
 Chronic treatment: a prescription in the year of 
diagnosis and every year after that, for five years 
 Intermittent treatment: a prescription in the year of 
diagnosis and at least one of five subsequent years 
 Short term treatment: a prescription in the year of 
diagnosis, but not in any of five subsequent years 
 Delayed treatment: no prescription in the year of 
diagnosis, but a prescription in years 2-5  
 No treatment: never received a prescription 
37 
Prescription-days over five years by group 
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Implications 
 Research and policy has largely focussed on the initial 
prescribing decision and targeting of  antidepressant drug 
treatment to more severe depression 
 
 Increased attention should focus on appropriate longer 
term prescribing, monitoring, and medication review 
 
 Some patients on long-term treatment find it hard to 
come off and need active review to help them do that  
Leydon GM, Rodgers L, Kendrick T.  A qualitative study of patient views on 
discontinuing selective serotonin reuptake inhibitors. Family Practice 2007 doi: 
10.1093/fampra/cmm069. 
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Management of depression in UK 
general practice in relation to scores 
on depression severity questionnaires: 
analysis of medical record data 
Tony Kendrick, Chris Dowrick,  Anita McBride, 
Amanda Howe, Pam Clarke, Sue Maisey, Mike Moore 
& Peter Smith 
Universities of Southampton, Liverpool and East Anglia 
 
Funded by Lilly, Lundbeck, Servier and Wyeth pharmaceuticals 
 
British Medical Journal 2009;338:b750.  
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Aim 
To determine if rates of antidepressant drug 
prescribing and referrals to specialist services 
varied in line with patients’ scores on the QOF 
depression severity questionnaires (PHQ-9 and 
HAD-D) 
Other potentially important predictors taken into 
account:  
 Demographic factors 
 Past history of depression 
 Concurrent physical illness, including diabetes and 
coronary heart disease 
42 
Methods 
 Analysis of anonymised medical record data 
 38 general practices in Southampton, Liverpool, 
and Norfolk 
 2294 patients assessed with severity 
questionnaires between April 2006 and March 
2007 inclusively (first year of their introduction) 
 Outcome measures:  
 Rates of prescribing of antidepressants  
 Referrals to specialist mental health or social services 
(Counsellor, Primary Care Mental Health Worker, Psychologist, 
Psychiatrist, or Social Worker) 
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Item of management 
received 
Number (%) of patients in receipt of item 
by PHQ-9 severity category 
Minimal 
(N = 85) 
Mild 
(N = 189) 
Moderate 
to severe  
(N = 1384) 
Total 
(N = 1658) 
Prescription for an 
antidepressant  
23 
(27.1) 
92 
(48.7) 
1195 
(86.7) 
1310 
(79.0)*** 
Any referral to mental 
health/ social services 
11 
(12.9) 
31 
(16.4) 
351 
(25.36) 
393 
(23.7)** 
Significance of differences between severity categories (χ2 test, with an adjustment to allow for clustering): **p<0.01; ***p<0.001  
Intervention and severity on PHQ-9 
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Item of management received 
Number (%) of patients in receipt of item 
by HAD-D severity category 
Minimal 
(N = 121) 
Mild 
(N = 138) 
Moderate 
to severe 
(N = 325) 
Total 
(N = 584) 
Prescription for an 
antidepressant  
64 
(52.9) 
108 
(78.3) 
292 
(89.9) 
464 
(79.5)*** 
Any referral to mental health/ 
social services 
16 
(13.2) 
23 
(16.7) 
80 
(24.6) 
119 
(20.4) 
Significance of differences between severity categories (χ2 test, with an adjustment to allow for clustering): ***p<0.001  
Intervention and severity on HAD-D 
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Classification: differences between measures 
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Item of 
management 
 
Severity 
 
Age  
65+  
 
Past history 
of 
depression 
 
Diabetes 
mellitus 
 
 
Coronary 
heart 
disease 
 
Southampton v 
Liverpool and 
Norfolk 
PHQ-9 
patients 
 
Prescription 
 
+ + + 
 
+ + + 
 
_ _ 
 
_ _ 
 
+ + + 
 
 
Referral 
 
_ _ _ 
 
_ _ 
 
_ _ 
 
HAD-D 
patients 
 
Prescription 
 
+ + + 
 
+ + 
 
 
Referral + + + _ _ _ 
Logistic regression models 
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Main findings 
 Overall ~ 80% of patients assessed received a prescription for 
an antidepressant, and ~ 20% were referred to specialist 
services  
 Prescriptions and referrals were significantly associated with 
higher severity measure scores 
 However, overall rates of treatment and referral were very 
similar for patients assessed with different measures, despite 
the fact that the PHQ-9 classified > 80% of patients as 
moderately to severely depressed and in need of treatment, 
compared to only ~ 55% for the HAD-D   
 Rates of intervention were lower for older patients, and for 
patients with comorbid physical illness including coronary heart 
disease and diabetes 
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Summary: GP use of antidepressants 
 Diagnosis and prescribing of antidepressants by GPs has 
remained remarkably consistent through the 1990s and 2000s 
 Approximately 80% of patients diagnosed are treated 
 Most patients take them for too short a time 
 A small proportion may be kept on them for too long 
 Analysis of records suggests GPs largely decide on drug 
treatment on the basis of perceived severity 
 Age and physical illness are also taken into account 
 The two most widely used severity questionnaires perform 
inconsistently in practice, which brings them into disrepute 
 Future research and policy needs to focus on the duration of 
prescribing, and follow-up monitoring, as well as the initial 
decision to prescribe 
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Patients value being listened to 
 Connection: helping them to feel understood 
 Reflection: helping them to clarify or reframe 
 What’s wrong with them (medical model) 
 What’s wrong with their situation (social model) 
 Acceptance: when others are condemning them 
 Bearing witness: helping them feel they are not alone 
 Reassurance: that they are not going mad 
 Ventilation: to help them get things off their mind  
 Encouragement: that they will get better 
52 
Patients often don’t feel listened to 
 Lack of time  
 The doctor seems rushed 
 Ten minute appointments aren’t long enough 
 Inattention 
 The doctor is preoccupied with the computer, or making notes 
 Perceived lack of receptiveness/acknowledgement 
 The patient feels less worthy than physically ill patients 
 The doctor dismisses the problem  
 Superficial response 
 The doctor decides too quickly to prescribe antidepressants 
 OK if GP refers on to someone who will listen 
 Counsellor, other professional 
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Improving Access to Psychological 
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IAPT programme 
•    Low intensity  
• Guided self-help 
• Behavioural activation 
•    High intensity  
• Cognitive Behaviour Therapy 
• Interpersonal Therapy 
 
 
•    Demonstration sites 
•  Doncaster  
•  Newham 
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Main Findings 
 The demonstration sites were able to treat 
hundreds of patients per month 
 Most therapy was low intensity, delivered 
by the telephone, lasting 4-5 sessions 
 The proportion of patients with mental 
health problems who received treatment 
increased six-fold from 1% to 6% 
 Use of Accident & Emergency was reduced 
 5% more patients got back to work 
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Problems with IAPT 
 Lack of continuity (due to staff turnover) or follow 
up problematic for patients 
 For some people practitioners could be experienced 
as impersonal 
 Some experienced little or no choice in referral or 
treatment options 
 Although hundreds more patients received 
treatment,  they were still only a small minority of 
the total with anxiety and depression 
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Summary: talking treatments 
 People need to feel listened to 
 GPs often can’t or don’t listen enough 
 Referral for therapy is associated with improved 
outcomes and less use of non-mental health care 
 However only a minority of patients who need 
referral can get it, due to limited funding 
 Some find outside therapists impersonal 
 Primary care teams may have to do more themselves 
 Training and supervision are essential 
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Exercise 
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And... 
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Humour 
 
 
 
 
Separated at birth? 
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